These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 35303522)
1. Overexpression of OTX1 promotes tumorigenesis in patients with esophageal squamous cell carcinoma. Chai J; Xu T; Yang Y; Yuan Y; Xu J; Liu J; Wang K; Lv Y; Chai J; Kang Y; Chen L; Qin J; Jia Q; Li M Pathol Res Pract; 2022 Apr; 232():153841. PubMed ID: 35303522 [TBL] [Abstract][Full Text] [Related]
2. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma. Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781 [TBL] [Abstract][Full Text] [Related]
4. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer. Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532 [TBL] [Abstract][Full Text] [Related]
5. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228 [TBL] [Abstract][Full Text] [Related]
6. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis. Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233 [TBL] [Abstract][Full Text] [Related]
8. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma. Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142 [TBL] [Abstract][Full Text] [Related]
9. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription. Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma]. Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413 [No Abstract] [Full Text] [Related]
11. ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma. Li J; Yang D; Zhang C; Wei S; Zhao R; Dai S; Shan B Biomed Res Int; 2022; 2022():5328192. PubMed ID: 35937390 [TBL] [Abstract][Full Text] [Related]
12. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma. Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144 [TBL] [Abstract][Full Text] [Related]
13. RIG-I Promotes Tumorigenesis and Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating DUSP6. Li L; Lv L; Xu JC; He Q; Chang N; Cui YY; Tao ZC; Zhu T; Qian LT Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982663 [TBL] [Abstract][Full Text] [Related]
14. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma. Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580 [TBL] [Abstract][Full Text] [Related]
15. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma. Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670 [TBL] [Abstract][Full Text] [Related]
16. Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery. Zhu T; Yang Q; Shao J; Chen Z; Cai B; Mao G Virchows Arch; 2021 Nov; 479(5):905-917. PubMed ID: 34313839 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma. Xu Y; Qiu M; Chen Y; Wang J; Xia W; Mao Q; Yang L; Li M; Jiang F; Xu L; Yin R Dis Esophagus; 2016 Nov; 29(8):950-958. PubMed ID: 26833746 [TBL] [Abstract][Full Text] [Related]
18. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10. Ding N; Sun X; Wang T; Huang L; Wen J; Zhou Y Int J Mol Med; 2018 Jul; 42(1):381-391. PubMed ID: 29693138 [TBL] [Abstract][Full Text] [Related]
19. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma. Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964 [TBL] [Abstract][Full Text] [Related]
20. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]